An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation

2001 ◽  
Vol 29 (6) ◽  
pp. 1164-1168 ◽  
Author(s):  
Hidesaku Asakura ◽  
Yasuo Ontachi ◽  
Tomoe Mizutani ◽  
Minori Kato ◽  
Masanori Saito ◽  
...  
CHEST Journal ◽  
1992 ◽  
Vol 101 (3) ◽  
pp. 816-823 ◽  
Author(s):  
Francois Fourrier ◽  
Claude Chopin ◽  
Jenny Goudemand ◽  
Sylvie Hendrycx ◽  
Claudine Caron ◽  
...  

1990 ◽  
Vol 60 (4) ◽  
pp. 321-330 ◽  
Author(s):  
Toshikazu Tanaka ◽  
Toshimasa Tsujinaka ◽  
Jun-ichi Kambayashi ◽  
Masahiko Higashiyama ◽  
Masayuki Yokota ◽  
...  

1995 ◽  
Vol 10 (3) ◽  
pp. 145-152 ◽  
Author(s):  
Robert M. Hardaway

Disseminated intravascular coagulation (DIC) was first observed clinically in a case of sepsis following severe trauma. It was postulated that the observed clotting defect and bleeding were due to the using up of clotting factors in an episode of intravascular clotting. It was also postulated that the multiple organ failure observed was due to obstruction of the microcirculation of the organs by microclots. Evidence for this process was worked out in many animal studies. It was then postulated that if these microclots could be lysed before organ necrosis was produced, organ failure could be prevented. This prevention was shown to be possible in animals. It was then tried in humans using plasminogen activators, and the approach was found to be effective. Using a low dose of plasminogen activator over a 24-hour period caused no changes in the coagulation profile or bleeding.


Sign in / Sign up

Export Citation Format

Share Document